share_log

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

为什么Ultragenyx制药股价下跌了约9%?以下是周一午盘交易中其他股票的走势
Benzinga ·  04/15 14:11
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Ultragenyx Pharmaceutical Inc.(纳斯达克股票代码:RARE)的股价在周一的交易中大幅下跌,此前该公司公布了针对Angelman综合征的1/2期研究的新数据,安杰尔曼综合征是一种导致发育障碍和神经相关症状的遗传性疾病。GTX-102
Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday.
周一,Ultragenyx Pharmaceutical股价下跌9.4%,至42.46美元。
Here are some other stocks moving in today's mid-day session.
以下是今天中午交易时段中其他一些走势的股票。
Gainers
获胜者
Soligenix, Inc. (NASDAQ:SNGX) shares surged 71.5% to $0.6679 after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA. Longeveron Inc. (NASDAQ:LGVN) surged...
Soligenix, Inc.(纳斯达克股票代码:SNGX)股价飙升71.5%,至0...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发